| abstract |
A pyrazolo[1,5-a]pyridine derivative represented by the formula (I) and a medically acceptable salt thereof have an excellent MAPKAP-K2 inhibitory activity. Therefore, a pharmaceutical comprising the compound as an active ingredient is expected to be useful for the treatment or prevention of a MAPKAP-K2-mediated disorder such as an inflammatory disorder, an autoimmune disease, destructive osteopathy, cancer and/or tumor growth. |